Literature DB >> 16422979

Summary of the recommendations on sexual dysfunctions in men.

Tom F Lue1, François Giuliano, Francesco Montorsi, Raymond C Rosen, Karl-Erik Andersson, Stanley Althof, George Christ, Dimitrios Hatzichristou, Mark Hirsch, Yasasuke Kimoto, Ronald Lewis, Kevin McKenna, Chris MacMahon, Alvaro Morales, John Mulcahy, Harin Padma-Nathan, John Pryor, Inigo Saenz de Tejada, Ridwan Shabsigh, Gorm Wagner.   

Abstract

INTRODUCTION: There are few published guidelines for the management of sexual dysfunctions in men and women, despite the prevalence and lack of attention to these problems. Disorders of sexual function in men include erectile dysfunction, orgasm/ejaculation disorders, priapism, and Peyronie's disease. AIM: To provide evidence-based and expert-opinion consensus guidelines for the clinical management of men's sexual dysfunctions.
METHODS: An International Consultation in collaboration with major urological and sexual medicine societies assembled over 200 multidisciplinary experts from 60 countries into 17 consultation committees. Committee members established the scope and objectives for each chapter. Following intensive review of available data and publications, committees developed evidence-based guidelines in each area. MAIN OUTCOME MEASURE: New algorithms and guidelines for assessment and treatment of men's sexual dysfunction were developed. The Oxford system of evidence-based review was systematically applied. Expert opinion was based on systematic grading of the medical literature, in addition to cultural and ethical considerations.
RESULTS: Recommendations and guidelines for men's sexual dysfunction are presented. These guidelines were developed as evidence-based, patient-centered, and multidisciplinary in focus. For the clinical assessment and diagnosis of ED, a basic evaluation was recommended for all patients, with optional and specialized testing reserved for special cases. A new treatment algorithm is proposed. This algorithm provides a clinically relevant guideline for managing ED in the large majority of men. New treatment guidelines and algorithms are provided for men's orgasm and ejaculation disorders, including premature ejaculation, retrograde and delayed ejaculation. Finally, expert opinion-based guidelines for the clinical management of priapism and Peyronie's disease are provided.
CONCLUSIONS: Additional research is needed to validate and extend these guidelines. Nonetheless, this summary encompasses the recommendations concerning men's sexual dysfunctions presented at the 2nd International Consultation on Sexual Medicine in Paris, France, June 28-July 1, 2003.

Entities:  

Mesh:

Year:  2004        PMID: 16422979     DOI: 10.1111/j.1743-6109.2004.10104.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  58 in total

1.  A novel approach for the surgical management of Peyronie's disease using an acellular, human dermis tissue graft: preliminary results.

Authors:  Ioannis Adamakis; Stavros I Tyritzis; Konstantinos G Stravodimos; Vasileios Migdalis; Dionysios Mitropoulos; Constantinos A Constantinides
Journal:  World J Urol       Date:  2010-10-06       Impact factor: 4.226

2.  Men's aging and sexual disorders: an update on diagnosis and treatment.

Authors:  Alvaro Morales
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

Review 3.  [Single base polymorphisms and erectile dysfunction].

Authors:  A Eisenhardt; H Rübben; H Sperling
Journal:  Urologe A       Date:  2008-12       Impact factor: 0.639

Review 4.  [Current therapeutic options for Peyronie's disease].

Authors:  A Hauptmann; T Diemer; W Weidner
Journal:  Urologe A       Date:  2013-10       Impact factor: 0.639

Review 5.  Sexual counselling for sexual problems in patients with cardiovascular disease.

Authors:  Molly Byrne; Sally Doherty; Bengt G A Fridlund; Jan Mårtensson; Elaine E Steinke; Tiny Jaarsma; Declan Devane
Journal:  Cochrane Database Syst Rev       Date:  2016-02-24

6.  [Peyronie's disease: diagnostics and therapy].

Authors:  A Hauptmann; T Diemer; W Weidner
Journal:  Urologe A       Date:  2011-05       Impact factor: 0.639

7.  A study of sexuality and health among older adults in the United States.

Authors:  Stacy Tessler Lindau; L Philip Schumm; Edward O Laumann; Wendy Levinson; Colm A O'Muircheartaigh; Linda J Waite
Journal:  N Engl J Med       Date:  2007-08-23       Impact factor: 91.245

Review 8.  A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?

Authors:  Konstantinos Hatzimouratidis; Dimitrios G Hatzichristou
Journal:  Drugs       Date:  2005       Impact factor: 9.546

9.  Orgasm is preserved regardless of ejaculatory dysfunction with selective alpha1A-blocker administration.

Authors:  K Kobayashi; N Masumori; R Kato; S Hisasue; R Furuya; T Tsukamoto
Journal:  Int J Impot Res       Date:  2009-06-18       Impact factor: 2.896

Review 10.  Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database.

Authors:  F Giuliano; G Jackson; F Montorsi; A Martin-Morales; P Raillard
Journal:  Int J Clin Pract       Date:  2009-11-09       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.